- Gastric cancer and metabolic syndrome
-
Hyeong Ho Jo
-
Kosin Med J. 2024;39(1):26-34. Published online March 22, 2024
-
DOI: https://doi.org/10.7180/kmj.24.108
-
-
2,133
View
-
34
Download
-
1
Citations
-
 Abstract
 PDF PubReader  ePub
- Gastric cancer (GC), a prevalent disease in Asian countries, presents a substantial global health challenge. The risk factors for GC include Helicobacter pylori infection, diet, smoking, alcohol, and metabolic syndrome (MetS). This review meticulously examines the intricate connections between MetS and GC, focusing on visceral adipocytes, hormonal factors, obesity, and their impact on survival outcomes. Visceral adipocytes, which secrete inflammatory cytokines and hormones, play a pivotal role in influencing cancer development. Hormonal factors demonstrate nuanced associations with specific GC subtypes, underscoring the complexity of their impact. Large-scale studies exploring obesity-related factors reveal sex-specific nuances and underscore the importance of considering overall weight and body composition. Furthermore, the review explores the impact of eradication therapy for H. pylori infection, which is the most significant factor in the onset of GC, on the components of MetS. Additionally, the influence of MetS on postoperative outcomes and survival in GC patients highlights the interplay between therapeutic interventions and lifestyle factors. This comprehensive exploration sheds light on the multifaceted relationship between MetS and GC, providing valuable insights for future research and preventive strategies.
-
Citations
Citations to this article as recorded by  - Chemotherapy for Metastatic Gastric Cancer
Sung Eun Kim, Moo In Park, Myung Hun Lee
The Korean Journal of Gastroenterology.2025; 85(1): 1. CrossRef
|
KOSIN UNIVERSITY COLLEGE OF MEDICINE
